The roughly 48% gap between the trailing and forward EV/EBITDA suggests market pricing already treats the recent margin trough as transient rather than structural; because the company skipped guidance at its October 2026 earnings event, that expected rebound is currently unanchored to management's own framework. At a P/S of 1.00 against approximately 2.5% trailing revenue growth, the valuation appears to rest on margin repair rather than volume expansion, meaning further input-cost pressure or continued QSR traffic softness could leave the multiple exposed. A dividend yield of 3.1% offers some valuation support, but it does not offset the sensitivity of a 17.74x trailing multiple to earnings that declined 54.3% year-over-year in the most recent quarter.

With asset turnover essentially flat near 0.22–0.23x across the entire window, the deterioration in ROIC appears to be a margin story rather than an efficiency story, as operating margin has fallen from 13.2% in 2024Q4 to 4.9% in 2027Q1. Because roughly two-thirds of the asset base sits in net property, plant and equipment and goodwill, returns look to be decaying while the capital footprint remains committed, which implies recovery would depend on capacity utilization normalizing toward the 90–95% threshold rather than on reducing investment. Even the strongest quarters in the series produced ROIC at or below 3.2%, a level that appears unlikely to clear a typical weighted average cost of capital, so the compounding case is not yet visible in the reported figures.

Inventory days have fallen sharply from 107 to 63 while receivables have been stable near 40–44 days throughout the period, implying customer collection discipline is not the variable under pressure; the notable movement is on the supplier side, where shorter payables terms would consume cash rather than release it. The volatility in these figures, with inventory days swinging from 87 to 107 and back, is consistent with the previously disclosed ERP-driven dislocations, so normalization of the cycle warrants monitoring before a steady-state efficiency trend is assumed. With operating cash flow sensitive to these swings, investors should monitor whether payables days stabilize as ERP effects wash out.

Relative to this group, Lamb Weston carries the highest leverage and among the lowest returns on invested capital, yet its valuation multiple sits within striking distance of Freshpet's 23.96x P/E and 18.65x EV/EBITDA — a profile that would normally attach to a high-growth specialty producer rather than a decelerating commodity processor. The premium appears attributable to category share position and the visibility of QSR supply contracts rather than to demonstrated capital efficiency, which suggests the market is either anticipating a structural margin repair or that the multiple is exposed to de-rating if the 2.5% revenue growth trajectory persists. Conagra's negative P/E and -8.1% ROIC are distorted by its own restructuring, so Nomad Foods at 10.81x P/E with 5.5% ROIC is arguably the more informative benchmark for where multiples could settle.